Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
British Journal of Cancer
Lawrence D MayerMarcel B Bally
Journal of Controlled Release : Official Journal of the Controlled Release Society
Anitha M ThomasMarcel B Bally
Cancer Chemotherapy and Pharmacology
Alain G MusendeEmma Tomlinson Guns
International Journal of Pharmaceutics
Xiaojuan YangRobert J Lee
International Journal of Nanomedicine
Mohamed WehbeMarcel B Bally